248 related articles for article (PubMed ID: 15714207)
1. NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle.
Wyke SM; Tisdale MJ
Br J Cancer; 2005 Feb; 92(4):711-21. PubMed ID: 15714207
[TBL] [Abstract][Full Text] [Related]
2. Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation.
Wyke SM; Russell ST; Tisdale MJ
Br J Cancer; 2004 Nov; 91(9):1742-50. PubMed ID: 15477867
[TBL] [Abstract][Full Text] [Related]
3. Role of protein kinase C and NF-kappaB in proteolysis-inducing factor-induced proteasome expression in C(2)C(12) myotubes.
Smith HJ; Wyke SM; Tisdale MJ
Br J Cancer; 2004 May; 90(9):1850-7. PubMed ID: 15150589
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappaB.
Whitehouse AS; Tisdale MJ
Br J Cancer; 2003 Sep; 89(6):1116-22. PubMed ID: 12966435
[TBL] [Abstract][Full Text] [Related]
5. Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway.
Whitehouse AS; Khal J; Tisdale MJ
Br J Cancer; 2003 Aug; 89(4):737-45. PubMed ID: 12915888
[TBL] [Abstract][Full Text] [Related]
6. Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway.
Wyke SM; Tisdale MJ
Life Sci; 2006 May; 78(25):2898-910. PubMed ID: 16343552
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate.
Smith HJ; Wyke SM; Tisdale MJ
Cancer Res; 2004 Dec; 64(23):8731-5. PubMed ID: 15574784
[TBL] [Abstract][Full Text] [Related]
8. Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor.
Gomes-Marcondes MC; Smith HJ; Cooper JC; Tisdale MJ
Br J Cancer; 2002 May; 86(10):1628-33. PubMed ID: 12085214
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of induction of muscle protein degradation by angiotensin II.
Russell ST; Wyke SM; Tisdale MJ
Cell Signal; 2006 Jul; 18(7):1087-96. PubMed ID: 16257180
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes.
Li YP; Reid MB
Am J Physiol Regul Integr Comp Physiol; 2000 Oct; 279(4):R1165-70. PubMed ID: 11003979
[TBL] [Abstract][Full Text] [Related]
11. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation.
Parcellier A; Schmitt E; Gurbuxani S; Seigneurin-Berny D; Pance A; Chantôme A; Plenchette S; Khochbin S; Solary E; Garrido C
Mol Cell Biol; 2003 Aug; 23(16):5790-802. PubMed ID: 12897149
[TBL] [Abstract][Full Text] [Related]
12. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF).
Lorite MJ; Smith HJ; Arnold JA; Morris A; Thompson MG; Tisdale MJ
Br J Cancer; 2001 Jul; 85(2):297-302. PubMed ID: 11461093
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction pathways involved in proteolysis-inducing factor induced proteasome expression in murine myotubes.
Smith HJ; Tisdale MJ
Br J Cancer; 2003 Nov; 89(9):1783-8. PubMed ID: 14583784
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia.
Sanders PM; Russell ST; Tisdale MJ
Br J Cancer; 2005 Aug; 93(4):425-34. PubMed ID: 16052213
[TBL] [Abstract][Full Text] [Related]
15. Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle.
Mirza KA; Tisdale MJ
Br J Cancer; 2014 Aug; 111(5):903-8. PubMed ID: 25101564
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation.
Eley HL; Tisdale MJ
J Biol Chem; 2007 Mar; 282(10):7087-97. PubMed ID: 17213191
[TBL] [Abstract][Full Text] [Related]
17. Blocking autophagy prevents bortezomib-induced NF-κB activation by reducing I-κBα degradation in lymphoma cells.
Jia L; Gopinathan G; Sukumar JT; Gribben JG
PLoS One; 2012; 7(2):e32584. PubMed ID: 22393418
[TBL] [Abstract][Full Text] [Related]
18. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
Tisdale MJ
J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
[TBL] [Abstract][Full Text] [Related]
19. Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysis-inducing factor and angiotensin II.
Russell ST; Eley H; Tisdale MJ
Cell Signal; 2007 Aug; 19(8):1797-806. PubMed ID: 17532611
[TBL] [Abstract][Full Text] [Related]
20. I-kappaBalpha depletion by transglutaminase 2 and mu-calpain occurs in parallel with the ubiquitin-proteasome pathway.
Kim DS; Han BG; Park KS; Lee BI; Kim SY; Bae CD
Biochem Biophys Res Commun; 2010 Aug; 399(2):300-6. PubMed ID: 20659425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]